Sale!

SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The SLC12A6 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a rare genetic disorder known as Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, the part of the brain that connects the two cerebral hemispheres, along with peripheral neuropathy, which affects the peripheral nerves.

To diagnose this condition, a genetic test focusing on the SLC12A6 gene can be conducted. DNA Labs UAE offers this specific genetic test to identify mutations in the SLC12A6 gene that are indicative of ACCPN. The test is crucial for accurate diagnosis and can aid in the management and treatment of the condition.

The cost of the SLC12A6 gene genetic test at DNA Labs UAE is 3200 AED. This test is a vital tool for families and individuals at risk of ACCPN, providing them with essential information for healthcare planning and intervention.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test

Are you or a loved one experiencing symptoms of agenesis of the corpus callosum with peripheral neuropathy (ACCPN)? DNA Labs UAE offers a comprehensive genetic test to help diagnose this rare condition.

Test Details

The SLC12A6 gene is associated with ACCPN, a genetic condition characterized by the absence or underdevelopment of the corpus callosum and peripheral neuropathy. Our genetic test utilizes Next-Generation Sequencing (NGS) technology to analyze the entire SLC12A6 gene for any mutations or variations that may be causing the condition.

Test Components and Price

  • Test Name: SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test
  • Price: 3200.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

Reports are typically delivered within 2 to 4 weeks.

Test Type

This test falls under the category of Neurological Disorders.

Referring Doctor

Our genetic test is conducted under the supervision of a qualified Neurologist.

Test Department

Our Genetics department handles all aspects of this test.

Pre Test Information

Prior to the test, we recommend a genetic counseling session to gather clinical history and draw a pedigree chart of family members affected by ACCPN.

Why Choose Our Test?

Our SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test provides valuable information about the cause of ACCPN. With this knowledge, healthcare professionals can develop effective treatment and management strategies for affected individuals and their families.

Test Name SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 25 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC12A6 Gene Agenesis of the corpus callosum with peripheral neuropathy
Test Details

The SLC12A6 gene is associated with a rare genetic condition called agenesis of the corpus callosum with peripheral neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, a structure that connects the two hemispheres of the brain, and peripheral neuropathy, which is a disorder of the nerves that transmit information from the brain and spinal cord to the rest of the body.

NGS genetic testing can be used to detect mutations in the SLC12A6 gene, which can help diagnose ACCPN. This test involves sequencing the entire SLC12A6 gene to identify any changes or variations that may be causing the condition. The results of this test can provide important information about the cause of ACCPN and can help guide treatment and management strategies for affected individuals and their families.